2016-003981-15
Assessment of Hepatitis B Vaccine Manufactured by a Modified Process in Healthy Neonates (babies 1 to 10 days old)
Merck & Co., Inc.·EU Clinical Trials Register
Study focus
- Disease/Condition
- Hepatitis B
Sponsor & location
- Primary sponsor
- Merck & Co., Inc.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
a. Infant born to a mother with no prenatal care.
ICD-10 classifications
Acute hepatitis BAcute hepatitis B without delta-agent and without hepatic comaAcute delta-(super)infection in chronic hepatitis BChronic viral hepatitis B without delta-agentChronic viral hepatitis B without delta-agent : other and unspecified phase
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2016-003981-15
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2016-003981-15 through Pure Global AI's free database. This phase not specified trial is sponsored by Merck & Co., Inc. and is currently status unknown. The study focuses on Hepatitis B.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.